v3.26.3
Discontinued Operations - Schedule of Details of Loss from Discontinued Operations (Parenthetical) (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2026
Jun. 30, 2026
Sep. 30, 2026
Mar. 31, 2026
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue [1]     $ (29,285,000)  
Recorded liability of closing date       $ 3,300,000
Additional charge related to litigation matters settled $ 7,500,000 $ 4,200,000    
Indemnification liability remained     0  
Illumina        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue     29,800,000  
SomaScan Business        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenue     29,800,000  
Discontinued operations     29,800,000  
Deferred revenue     $ 600,000  
[1] Deferred revenue related to the Collaboration Agreement with Illumina was fully recognized upon the sale of the Disposed Entities. The Company has classified this revenue within discontinued operations consistent with the treatment of all SomaScan Business-related activities. Please see Note 3, Discontinued Operations, for more information.